Head of U.S. Generic Drugs Association to Step Down

Kathleen Jaeger will step down as head of the Generic Pharmaceutical...
Kathleen Jaeger will step down as head of the Generic Pharmaceutical Association at the end of June.

Kathleen Jaeger, the chief lobbyist for the generic drugs industry during the debate over U.S. healthcare reform, is resigning as head of the Generic Pharmaceutical Association, the trade group said on Tuesday.

Generic drugmakers lost out in the recently passed reform legislation which gave makers of branded biotech drugs 12 years of exclusive rights to market and sell a product before generic copycats can enter the market. Generic firms, which can sell drugs cheaper because they do less expensive research and development work, had lobbied for an exclusivity period of five to seven years.

Jaeger's resignation is effective June 30 and she will remain an adviser to trade group through the end of 2010.

Last month, Teva Pharmaceutical Industries, the biggest generic drug company in the U.S. market, said it would leave the lobbying group by the end of June. The Israel-based company said in a letter to the trade association that it would advocate for its interests outside of the group, which it said was not meeting its potential.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.